CD8A and neoplasm: The stem-like CD8+ T cells then migrate to the tumor via chemokine signaling and express co-stimulatory receptors, maintaining a stem-like phenotype until a second phase of co-stimulation by APCs generates an effector transcriptional program necessary for tumor cell killing (Figure 1) [16].